Stefan Walbom Harders

Stefan Walbom Harders

Auto-generated profile, based on publicly available information

Stefan Walbom Harders

Department of Radiology, Aarhus University Hospital, Aarhus, Denmark

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 May 2011 in Acta Radiologica
Verified
Journal Article
Closed access
PDF file
SHStefan Walbom Harders
Stefan Walbom Harders
HMHans Henrik Madsen
Hans Henrik Madsen
TRTorben Riis Rasmussen
Torben Riis Rasmussen
HHHenrik Hager
Henrik Hager
FRFinn Rasmussen
Finn Rasmussen
Background A solitary pulmonary nodule (SPN) may represent early stage lung cancer. Lung cancer is a devastating disease with an overall 5-year mortality rate of approximately 84% but with early detection and surgery as low as 47%. Currently a contrast-enhanced multiple-row detector CT (MDCT) scan is the first examination when evaluating patients with suspected lung cancer. Purpose To apply an additional high resolution CT (HRCT) to SPNs to test whether certain morphological characteristics are associated with malignancy, to assess the diagnostic accuracy of HRCT in the characterization of SPNs, and to address the reproducibility of all measures. Material and Method Two hundred and thirteen participants with SPNs were included in a follow-up study. Blinded HRCT images were assessed with regard to margin risk categories (MRCs), calcification patterns and certain other characteristics and overall malignancy potential ratings (MPRs) were given. Morphological characteristics were tested against reference standard and ROC methodology was applied to assess diagnostic accuracy. Reproducibility was measured with Kappa statistics and 95% confidence intervals were computed for all results. Histopathology (90%) and CT follow-up (10%) were used as reference standard. Results MRCs (P < 0.001), calcification patterns (P = 0.003), and pleural retraction (P < 0.001) were all statistically significantly associated to malignancy. Reproducibility was moderate to substantial. Sensitivity, specificity, and overall diagnostic accuracy of HRCT were 98%, 23% and 87%, respectively. Reproducibility was substantial. Conclusion Statistically significant associations between SPN MRCs, calcification patterns, pleural retraction and malignancy were found. HRCT yielded a very high sensitivity and a somewhat lower specificity for malignancy. Reproducibility was high.

1 November 2013 in British Journal of Radiology
Verified
Journal Article
Closed access
SHS W Harders
S W Harders
HMH H Madsen
H H Madsen
HNH M Nellemann
H M Nellemann
TRT R Rasmussen
T R Rasmussen
JTJ Thygesen
J Thygesen
FRF Rasmussen
F Rasmussen
To examine whether dynamic contrast-enhanced CT (DCE-CT) could be used to characterise and safely distinguish between malignant and benign lung tumours in patients with suspected lung cancer. Using a quantitative approach to DCE-CT, two separate sets of regions of interest (ROIs) in tissues were placed in each tumour: large ROIs over the entire tumour and small ROIs over the maximally perfused parts of the tumour. Using mathematical modelling techniques and dedicated perfusion software, this yielded a plethora of results. First, because of their non-normal distribution, DCE-CT measurements must be analysed using log scale data transformation. Second, there were highly significant differences between large ROI and small ROI measurements (p<0.001). Thus, the ROI method used in a given study should always be specified in advance. Third, neither quantitative parameters (blood flow and blood volume) nor semi-quantitative parameters (peak enhancement) could be used to distinguish between malignant and benign tumours. This was irrespective of the method of quantification used for large ROIs (0.13

3 June 2014 in Cancer Imaging
Verified
Journal Article
Open access
SHStefan Walbom Harders
Stefan Walbom Harders
HMHans Henrik Madsen
Hans Henrik Madsen
KHKarin Hjorthaug
Karin Hjorthaug
AAAnne Kirstine Arveschoug
Anne Kirstine Arveschoug
TRTorben Riis Rasmussen
Torben Riis Rasmussen
FRFinn Rasmussen
Finn Rasmussen
After the diagnosis Non-Small-Cell Lung Carcinoma (NSCLC) has been established, consideration must turn toward the stage of disease, because this will impact directly on management and prognosis. Staging is used to predict survival and to guide the patient toward the most appropriate treatment regimen or clinical trial. Distinguishing malignant involvement of the mediastinal lymph nodes (N2 or N3) from the hilar lymph nodes, or no lymph nodes (N0 or N1) is critical, because malignant involvement of N2 or N3 lymph nodes usually indicates non–surgically resectable disease. The purpose of this study was to examine and compare CT versus integrated F18-FDG PET/low dose CT (FDG PET/CT) for mediastinal staging in NSCLC, and the desire was to safely distinguish between malignant and benign lesions without the need for invasive procedures. All results were controlled for reproducibility. 114 participants with NSCLC were included in a prospective cohort study. Blinded CT and FDG PET/CT images were reviewed. The participants’ mediastinums were staged based on lymph node sizes (CT), or on FDG uptake (FDG PET/CT). Reference standard was tissue sampling. We found that there was no measureable difference between CT and FDG PET/CT mediastinal staging results; overall two-thirds of the participants in the study were correctly staged, and almost one-third of the participants were falsely staged. Neither CT nor FDG PET/CT could obviate the need for further invasive staging prior to thoracotomy in patients with NSCLC; for that purpose, the results of both modalities were too meagre. Therefore, these patients still depend on invasive staging methods. In our study, invasive staging was accomplished by mediastinoscopy. However, today this is increasingly replaced by EBUS or EUS.

1 January 2012 in Cancer Imaging
Verified
Journal Article
Closed access
SHStefan Walbom Harders
Stefan Walbom Harders
HMHans Henrik Madsen
Hans Henrik Madsen
KHKarin Hjorthaug
Karin Hjorthaug
AAAnne Kirstine Arveschoug
Anne Kirstine Arveschoug
TRTorben Riis Rasmussen
Torben Riis Rasmussen
FRFinn Rasmussen
Finn Rasmussen
Original article: Characterization of pulmonary lesions in patients with suspected lung cancer: computed tomography versus [18F]fluorodeoxyglucose-positron emission tomography/computed tomography - Cancer Imaging Original article: Characterization of pulmonary lesions in patients with suspected lung cancer: computed tomography versus [18F]fluorodeoxyglucose-positron emission tomography/computed tomography - Pulmonary nodules are of high clinical importance, given they may prove to be an early manifestation of lung cancer. Pulmonary nodules are small, focal, radiographic opacities that may be solitary or multiple. A solitary pulmonary nodule is a single, small (≤30 mm in diameter) opacity. Larger opacities are called masses and are often malignant. As imaging techniques improve and more nodules are detected, the optimal management of pulmonary nodules remains unclear. However, the question of malignancy of any given nodule remains the same.

1 July 2012 in British Journal of Radiology
Verified
Journal Article
Closed access
SHS W Harders
S W Harders
HMH H Madsen
H H Madsen
KHK Hjorthaug
K Hjorthaug
MRM Rehling
M Rehling
TRT R Rasmussen
T R Rasmussen
FRF Rasmussen
F Rasmussen
Objectives: A contrast-enhanced multidetector CT (MDCT) scan is the first choice examination when evaluating patients with suspected lung cancer. However, while the clinical focus is on CT, research focus is on molecular biological methods whereby radiolabelled pharmaceuticals are injected into participants and target malignant lung tumours. We examined whether a contrast-enhanced MDCT scan supplied with an additional non-contrast enhanced high-resolution CT scan, or a newer but more expensive 99mTc depreotide single photon emission CT (SPECT) scan, was the better first-choice examination for the work-up of pulmonary lesions. Furthermore, we examined whether a 99mTc depreotide SPECT scan was an appropriate second-choice examination for patients with indeterminate lesions. Methods: 140 participants were included in the analysis. CT images were given a malignancy potential rating of 1, 2 or 3 with higher rating being indicative of disease. 99mTc depreotide SPECT images were graded either positive or negative. Histopathology and CT follow-up were used as reference standard. Sensitivity, specificity and diagnostic accuracy were calculated. Results: Overall sensitivity, specificity and diagnostic accuracy of CT were 97%, 30% and 84%, respectively. Overall sensitivity, specificity and diagnostic accuracy of 99mTc depreotide SPECT were 94%, 58% and 76%, respectively. For indeterminate lesions sensitivity, specificity and diagnostic accuracy of 99mTc depreotide SPECT were 71%, 68% and 69%, respectively. Conclusion: Both CT and 99mTc depreotide SPECT made valuable contributions to the evaluation of pulmonary lesions. 99mTc depreotide SPECT results were not superior to CT results and did not contribute further to the diagnostic work-up. Regarding indeterminate lesions, 99mTc depreotide SPECT sensitivity was too low.

1 November 2012
Verified
Journal Article
Closed access
SHStefan Walbom Harders
Stefan Walbom Harders